CompanyGraph
Jiangxi Everbright Measurement & Control Technology Co. Ltd.
300906 · SZSE · China
rym.com.cnFinancials as of FY2025
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleRevenue is $26.36M, lower than 95% of all stocks globally
- PositionProfit margin is 31.2%, higher than 95% of its Scientific & Technical Instruments peers (median 6.4%)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.52%Below 5Y avg (1.46%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
21.8%Sustainable
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
2.29BCNY341.53M · vs all stocks (USD)
Trailing P/E
41.46xvs Scientific & Technical Instruments peers
Revenue (TTM)
176.63MCNY26.36M · vs all stocks (USD)
Profit Margin
31.24%vs Scientific & Technical Instruments peers
Beta
0.4430xvs all stocks
52-Week Change
-4.47%vs all stocks
Market Capitalization
2.29BCNY341.53M · vs all stocks (USD)
Enterprise Value
1.79BCNY267.71M · vs all stocks (USD)
Trailing P/E
41.46xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
12.96xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
2.46xvs Scientific & Technical Instruments peers
Enterprise to Revenue
10.16xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
30.94xvs Scientific & Technical Instruments peers
Gross Margin
43.41%vs Scientific & Technical Instruments peers
Profit Margin
31.24%vs Scientific & Technical Instruments peers
Operating Margin
14.63%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
3.45%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
6.08%vs Scientific & Technical Instruments peers
Revenue (TTM)
176.63MCNY26.36M · vs all stocks (USD)
Revenue per Share (TTM)
2.21CNYUpdated Sep 21, 2026Quarterly Revenue Growth
13.40%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
93.70MCNY13.98M · vs all stocks (USD)
EBITDA (TTM)
64.09MCNY9.56M · vs all stocks (USD)
Net Income (TTM)
55.18MCNY8.23M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-44.10%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
-43.95MCNY-6.56M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-266.63MCNY-39.79M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.52%vs all stocks
5-Year Average Dividend Yield
1.46%vs all stocks
Payout Ratio
21.75%vs Scientific & Technical Instruments peers
Revenue
170.60MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
81.02MCNYFY2025 · Dec 31, 2025Gross Profit
89.58MCNYFY2025 · Dec 31, 2025Operating Income
55.05MCNY8.22M · vs all stocks (USD)
Pre-tax Income
66.26MCNYFY2025 · Dec 31, 2025Income Tax Expense
8.90MCNYFY2025 · Dec 31, 2025Net Income
57.36MCNYFY2025 · Dec 31, 2025EBIT
66.68MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
72.23MCNYFY2025 · Dec 31, 2025Research & Development
16.49MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
6.93MCNYFY2025 · Dec 31, 2025Other Operating Expenses
1.92MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.25MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
422.26KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7170CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7170CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
80.00MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
80.00MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
57.36MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-43.85MCNYFY2025 · Dec 31, 2025Free Cash Flow
-48.35MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
656.64MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
57.36MCNYFY2025 · Dec 31, 2025Other Non-cash Items
422.26KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-92.18MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-9.45MCNYFY2025 · Dec 31, 2025Capital Expenditures
-4.51MCNYFY2025 · Dec 31, 2025Purchase of Investments
-580.50MCNYFY2025 · Dec 31, 2025Sale of Investments
495.86MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-89.15MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-40.29MCNYFY2025 · Dec 31, 2025Other Financing Charges
18.23MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-22.06MCNYFY2025 · Dec 31, 2025Shares Outstanding
80.00MSharesUpdated Sep 21, 2026Float Shares
34.93MSharesUpdated Sep 21, 2026% Held by Insiders
58.53%vs all stocks
% Held by Institutions
2.75%vs all stocks
Total Cash (MRQ)
495.18MCNY73.89M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.19CNYUpdated Sep 21, 2026Total Debt (MRQ)
460.69KCNY68.74K · vs all stocks (USD)
Current Ratio (MRQ)
11.31xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
11.62CNYUpdated Sep 21, 2026Total Assets
1.06BCNY158.18M · vs all stocks (USD)
Total Current Assets
988.92MCNYFY2025 · Dec 31, 2025Total Liabilities
138.49MCNYFY2025 · Dec 31, 2025Total Non-current Assets
71.12MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.06MCNYFY2025 · Dec 31, 2025Total Current Liabilities
136.44MCNYFY2025 · Dec 31, 2025Cash
656.64MCNYFY2025 · Dec 31, 2025Cash Equivalents
5.26MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
661.90MCNYFY2025 · Dec 31, 2025Accounts Receivable
172.83MCNYFY2025 · Dec 31, 2025Inventory
16.36MCNYFY2025 · Dec 31, 2025Accounts Payable
95.02MCNYFY2025 · Dec 31, 2025Short-term Debt
18.58MCNYFY2025 · Dec 31, 2025Other Current Liabilities
500.00KCNYFY2025 · Dec 31, 2025Common Stock (Book)
80.00MCNYFY2025 · Dec 31, 2025Retained Earnings
232.31MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
921.54MCNY137.51M · vs all stocks (USD)
52-Week Low
20.71CNYUpdated Sep 21, 202652-Week High
39.99CNYUpdated Sep 21, 202652-Week Change
-4.47%vs all stocks
Beta
0.4430xvs all stocks
50-Day MA
27.36CNYUpdated Sep 21, 2026200-Day MA
31.77CNYUpdated Sep 21, 2026Avg 10-Day Volume
1.01MSharesUpdated Sep 21, 2026Avg 30-Day Volume
1.68MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.6900CNYUpdated Sep 21, 20265 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 31.2%, higher than 95% of its Scientific & Technical Instruments peers (median 6.4%)Significant
Profit margin: 0.31Industry median: 0.06Industry P95: 0.21Peers compared: 64.00
Current ratio is 11.31×, higher than 95% of its Scientific & Technical Instruments peers (median 2.38×)Significant
Current ratio: 11.31Industry median: 2.38Industry P95: 7.22Peers compared: 64.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 8,234,114.192Operating Cash Flow (USD, TTM): -6,557,936.676
Financial Health
Altman Z-Score 11.56: safe zoneNotable
Altman Z-Score: 11.56
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Revenue is $26.36M, lower than 95% of all stocks globallySignificant
Revenue (USD): 26,356,196.183Global P5: 33,357,653.812
Companies that share the same coordination system — how they create, deliver, or capture value.
Suzhou Jinhong Shun Auto Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Longood Intelligent Electric Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Qingdao Victall Railway Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Tokushu Tokai Paper Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Unipres Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ningbo Lian Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Saint Bella Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenwu Energy Saving Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wuhan Citms Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingInterface
Xuancheng Valin Precision Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
United States Lime & Minerals Inc.
5 interpretationsMulti-Year Revenue, Profit, And Income GrowthCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration
Medlive Technology Co. Ltd.
4 interpretationsMulti-Year Revenue, Profit, And Income GrowthCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Hangzhou Sunrise Technology Co., Ltd.
4 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration